Funded Tech Companies
Veralox Therapeutics
Headquartered in Frederick, Veralox Therapeutics raised its funding from Sanofi-Genzyme BioVentures, Alexandria Venture Investments and Genesys Capital.
Company Overview
Company Name
Veralox Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
4539 Metropolitan Ct.
Frederick, MD 21704
USA
Frederick, MD 21704
USA
Phone
Website
Email Address
Company Background Information
Overview
We are developing first-in-class small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/18/2021
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Strovel
Chief Medical Officer
Michael Hanna
Chief Operating Officer
Matthew Boxer
Chief Scientific Officer
David Maloney
VP - R & D
Michael Holinstat
Company Investors
- Sanofi-Genzyme BioVentures (Daniel Mansuri)
- Alexandria Venture Investments
- Genesys Capital (Jamie Stiff)
- Point Field Partners
- Hatteras Venture Partners (Benjamin Scruggs)
- Maryland Momentum Fund
- Virginia Tech Carilion Innovation Fund
- TEDCO
- JDRF T1D Fund (Katie Ellias)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs